# Role of Soy Supplementation in Prostate Cancer Development

> **NCT00255125** · PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 86 (actual)

## Conditions studied

- Prostate Neoplasm

## Interventions

- **DRUG:** Soy Supplement
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00255125
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-04
- **Final completion:** 2009-10
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255125, "Role of Soy Supplementation in Prostate Cancer Development". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00255125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*